Jan 9, 2020
A new report on rheumatoid arthritis treatments published by a controversial cost appraiser is facing strong criticism from patient advocates, who say it minimizes the autoimmune disease as simply “morning stiffness” and “joint swelling”. The Institute for Clinical...
Aug 3, 2016
–Document will inform development of report for public deliberation by the Midwest CEPAC– August 1, 2016 – The Institute for Clinical and Economic Review (ICER) has posted a draft scoping document that will inform a report on drug therapies for rheumatoid arthritis....
